Law360 (December 2, 2019, 6:49 PM EST) -- United Kingdom antitrust enforcers in November cleared Salesforce's nearly $16 billion purchase of an analytics platform, Danaher tried to win the European Commission's blessing for its $21.4 billion proposed purchase of General Electric's biopharma business, and the Federal Trade Commission signed off on a drug divestiture to clear Bristol-Myers Squibb's $74 billion purchase of Celgene.
Here's a look at the major merger review developments last month.
The British government said Nov. 19 that it is likely to approve private equity firm Advent International Corp.'s £4 billion ($5.17 billion) takeover of U.K. defense company Cobham PLC after the companies offered concessions to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!